Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Indian J Exp Biol ; 2004 Aug; 42(8): 758-65
Article Dans Anglais | IMSEAR | ID: sea-59247

Résumé

L-Lysine HCI is being proposed to be a possible biocompatible adjuvant to enhance immune response by virtue of its probable non-specific bridging action and cellular proliferation properties. This proposal has been tried to be substantiated by designing an in vitro culture protocol, varying the concentration of L-lysine HCI and its further in vivo application. Splenic lymphocyte population has been extracted from mice and co-cultured with extracted mice macrophage population in presence of either Bacille Calmette Guerrin (BCG) or Hepatitis B surface antigen (HbsAg) and added L-lysine hydrochloride in culture media. Post incubation of these cultures, "taught" cell population has been adoptively transferred in naïve mice. These mice were then challenged by respective antigen dose, Change in Immune response with this challenge was noted. Antibody titre was followed in all the experiments as a measure of immune response. In adoptive immune transfer experiment of with HbsAg (AIT-HbsAg), similar to that with BCG (AIT-BCG), after the incubation period, antibody titre was higher in added lysine containing cultures in comparison with the control ones. Post transfer followed by antigen challenge, in AIT-BCG the expected augmentation in immune response was hardly visible. But in AIT-HbsAg, with the help of lysine booster, the animals responded better as far as the antibody titre is concerned.


Sujets)
Animaux , Vaccin BCG/administration et posologie , Femelle , Vaccins anti-hépatite B/administration et posologie , Facteurs immunologiques/administration et posologie , Immunothérapie adoptive , Lysine/administration et posologie , Souris , Souris de lignée BALB C , Vaccins antituberculeux/administration et posologie
2.
Indian J Physiol Pharmacol ; 2001 Jul; 45(3): 367-72
Article Dans Anglais | IMSEAR | ID: sea-108791

Résumé

Monoclonal antibodies (MAb) constitute the centre of all in-vitro diagnostic measures and almost all in-vivo therapeutic manoeuvres now. Production emphasis for these antibodies is having a current shift from animal-based large-scale culture to in-vitro bioreactor-based high-density culture. One of the major difficulties in high-density culture is end-metabolite accumulation in batch and fed-batch cultures in the forms of H+, NH4+ etc.. thereby reducing cellular growth and secretions. In the present study, effects of added proton carries--NAD and NADP--over and above the metabolic pools of the molecules, were examined on the cellular growth and secretion kinetics. Although NADP fortification showed a remarkable improvement in cellular growth (time dependent 200-300% improvements compared to controls) and size, cumulative MAb titre was better with NAD fortification. Combined additional loads of the proton carriers would be interesting to study in high density culture conditions.


Sujets)
Algorithmes , Animaux , Division cellulaire/effets des médicaments et des substances chimiques , Lignée cellulaire , Chromatographie en phase liquide à haute performance , Milieux de culture , Électrophorèse sur gel de polyacrylamide , Test ELISA , Hybridomes/effets des médicaments et des substances chimiques , Lysine/pharmacologie , Souris , Muromonab-CD3/biosynthèse , NAD/pharmacologie , Protons , Spectrophotométrie UV , Activation chimique
SÉLECTION CITATIONS
Détails de la recherche